A Study of Gene Polymorphisms Associated With Specific Presentations of Sexual Addiction

January 8, 2020 updated by: American Foundation for Addiction Research

Genetic Markers in Sexual Addiction

The study is intended to identify gene polymorphisms significantly associated with specific behavioral- and preoccupation-typologies of sexual addiction, and to identify additional potential genetic markers of sexual addiction. Research subjects with sexual addiction will be identified from the out-patient and in-patient populations of the investigative sites. Research subjects in the Control Group will be identified from the general population and from the student body of selected colleges. Approximately 1100 subjects will be enrolled in the study. Anticipating 10% drop-out, this is intended to generate a population of approximately 500 men and women clinically diagnosed with sexual addiction, and approximately 500 healthy men and women who do not meet diagnostic criteria for sexual addiction nor have psychopathology who will serve as the control population.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Arizona
      • Scottsdale, Arizona, United States, 85251
        • Psychological Counseling Services
      • Wickenburg, Arizona, United States, 85390
        • Gentle Path at The Meadows
    • California
      • Los Angeles, California, United States, 90025
        • Center for Healthy Sex
      • Los Angeles, California, United States, 90025
        • Triune Therapy Group
    • Mississippi
      • Hattiesburg, Mississippi, United States, 39402
        • Pine Grove Behavioral Health and Addiction Services
    • New York
      • Rochester, New York, United States, 14607
        • Kavod Center
    • Texas
      • Houston, Texas, United States, 77057
        • Center for Healthy Sexuality
    • Washington
      • Bellevue, Washington, United States, 98004
        • Seattle Christian Counseling

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Sexual Addict Group: individuals undergoing treatment for sexual addiction.

Control Group: individuals from general community who have no history of addiction or psychopathology

Description

Inclusion Criteria:

  • Sexual Addict Group

Age >= 18 years

Participating in sexual addiction treatment program

Sexual Addiction Screening Test--Revised (SAST-R) score >= 11

Meets at least 3 diagnostic criteria for sexual addiction

  • Control Group

Age >= 18 years

SAST-R score < 6

Exclusion Criteria:

  • Sexual Addiction Group

Serious mental illness

Significant cognitive impairment

  • Control Group

History of addiction

Current or previous Diagnostic and Statistical Manual (DSM-5) diagnosis

Serious mental illness

Significant cognitive impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Addict Group
In-patient and out-patient adult men and women who meet diagnostic criteria for sexual addiction.
Other: No Intervention
Control Group
Individuals from the general community and college student populations who have no history of identifiable psychopathology.
Other: No Intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Gene polymorphisms identified through polymerase chain reaction using fluorescent primers and restriction fragment length polymorphism analysis
Time Frame: Assessed at Enrollment
Assessed at Enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

American Foundation for Addiction Research

Collaborators

University of Alberta
University of Southern Mississippi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 17, 2016

Primary Completion (Anticipated)

June 1, 2020

Study Completion (Anticipated)

December 1, 2021

Study Registration Dates

First Submitted

June 17, 2016

First Submitted That Met QC Criteria

July 22, 2016

First Posted (Estimate)

July 26, 2016

Study Record Updates

Last Update Posted (Actual)

January 13, 2020

Last Update Submitted That Met QC Criteria

January 8, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AFAR 2016-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sexual Addiction

Clinical Trials on No Intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe